Yue Jie, Duan Xiaofeng, Gong Lei, Zhang Jianguo, Yu Zhentao
Department of Esophageal Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy of Tianjin City, Tianjin 300060, China.
Zhonghua Wei Chang Wai Ke Za Zhi. 2017 Nov 25;20(11):1283-1287.
To investigate the regularity of lymph node metastasis in cardiac carcinoma and its risk factors.
Complete clinicopathological data of 768 cardiac carcinoma patients undergoing radical resection and lymph node dissection were collected. A retrospective cohort study was performed to analyze the distribution of lymph node metastasis (lymph node metastasis rate=number of patients with lymph node metastasis/number of patients with lymph node dissection; lymph node metastasis frequency=number of metastatic lymph node/number of total resected lymph node) and the influence of clinicopathological factors on lymph node metastasis.
Of the 768 patients, 599 were male and 169 were female, with mean age of 61(28 to 85) years. According to gastric cancer staging criteria from the American Joint Cancer Association (AJCC) 7th edition in 2010, there was 256 cases in N0 stage, 171 cases in N1 stage, 181 cases in N2 stage, 160 cases in N3 phase; 18 cases in T1 stage, 30 cases in T2 stage, 9 cases in T3 stage, 711 cases in T4 stage. Borrmann type I( was found in 61 cases, type II( in 306 cases, type III( in 358 cases, type IIII( in 43 cases. The histological type was adenocarcinoma in 738 cases and signet ring cell carcinoma in 30 cases. A total of 9 183 lymph nodes were resected during operation for 768 patients with mean 12(0 to 57) nodes per case, while 510 patients were found to have 2 889 metastatic nodes; the lymph node metastasis rate was 66.4%(510/768), and lymph node metastasis frequency was 31.5%(2 889/9 183). Besides, 483 patients were found to have 2 759 metastatic lymph nodes and 8 246 resected lymph nodes in abdominal cavity with lymph node metastasis rate of 62.9%(483/768) and lymph node metastasis frequency of 33.5% (2 759/8 246); 57 patients were found to have 130 metastatic lymph nodes and 937 resected lymph nodes in thoracic cavity with lymph node metastasis rate of 7.4%(57/768) and lymph node metastasis frequency of 13.9%(130/937). Stations with the higher lymph node metastasis rate included paracardiac (left cardia: 38.8%, right cardia: 39.9%), lesser curvature of stomach(41.9%), left gastric artery (46%) and posterior pancreatic (38.5%). A total of 361 patients had resected lymph node number ≥12 during operation, while other 407 patients had number <12. Univariate analysis showed that Borrmann type, depth of tumor invasion and resected lymph node number were associated with lymph node metastasis. Lymph node metastasis rates of Borrmann type I(, II(, III( and IIII( patients were 55.7% (34/61), 62.7% (192/306), 73.7% (264/358) and 51.2%(22/43) respectively, and the difference was statistically significant (χ=18.115, P=0.000). Lymph node metastasis rates of T1, T2, T3, T4 stage patients were 0%(0/18), 30%(9/30), 100%(9/9) and 69.5%(494/711) respectively, and the difference was statistically significant (χ=63.971, P=0.000). Lymph node metastasis rate of patients with resected lymph node number ≥12 was 79.5%(287/361), which was significantly higher than 55.3%(225/407) of those with resected lymph node number <12(χ=50.496, P=0.000). Multivariate analysis revealed that higher T stage (OR=2.326, 95%CI: 1.758 to 3.078, P=0.000) and resected lymph node number ≥12(OR=2.998, 95%CI: 2.142 to 4.195, P=0.000) were independent risk factors of lymph node metastasis.
The lymph node metastasis rate of cardiac carcinoma is quite high. The metastasis occurs mainly in the surrounding of cardia, the small curvature of the stomach, the left artery of stomach and posterior pancreatic. The depth of tumor invasion and the number of lymph node dissection are independent risk factors of lymph node metastasis.
探讨贲门癌淋巴结转移规律及其危险因素。
收集768例行根治性切除及淋巴结清扫的贲门癌患者的完整临床病理资料。进行回顾性队列研究,分析淋巴结转移分布情况(淋巴结转移率=发生淋巴结转移患者数/行淋巴结清扫患者数;淋巴结转移频度=转移淋巴结数/总切除淋巴结数)及临床病理因素对淋巴结转移的影响。
768例患者中,男性599例,女性169例,平均年龄61(28~85)岁。根据2010年美国癌症联合委员会(AJCC)第7版胃癌分期标准,N0期256例,N1期171例,N2期181例,N3期160例;T1期18例,T2期30例,T3期9例,T4期711例。BorrmannⅠ型61例,Ⅱ型306例,Ⅲ型358例,Ⅳ型43例。组织学类型腺癌738例,印戒细胞癌30例。768例患者术中共切除9183枚淋巴结,平均每例12(0~57)枚,其中510例患者发现有2889枚转移淋巴结;淋巴结转移率为66.4%(510/768),淋巴结转移频度为31.5%(2889/9183)。此外,483例患者腹腔内有2759枚转移淋巴结及8246枚切除淋巴结,淋巴结转移率为62.9%(483/768),淋巴结转移频度为33.5%(2759/8246);57例患者胸腔内有130枚转移淋巴结及937枚切除淋巴结,淋巴结转移率为7.4%(57/768),淋巴结转移频度为13.9%(130/937)。淋巴结转移率较高的部位包括贲门旁(贲门左:38.8%,贲门右:39.9%)、胃小弯(41.9%)、胃左动脉(46%)和胰后(38.5%)。术中切除淋巴结数≥12枚的患者共361例,其余407例患者切除淋巴结数<12枚。单因素分析显示,Borrmann分型、肿瘤浸润深度及切除淋巴结数与淋巴结转移有关。BorrmannⅠ型、Ⅱ型、Ⅲ型、Ⅳ型患者的淋巴结转移率分别为55.7%(34/61)、62.7%(192/306)、73.7%(264/358)和51.2%(22/43),差异有统计学意义(χ=18.115,P=0.000)。T1、T2、T3、T4期患者的淋巴结转移率分别为0%(0/18)、30%(9/30)、100%(9/9)和69.5%(494/711),差异有统计学意义(χ=63.971,P=0.000)。切除淋巴结数≥12枚患者的淋巴结转移率为79.5%(287/361),显著高于切除淋巴结数<12枚患者的55.3%(225/407)(χ=50.496,P=0.000)。多因素分析显示,较高的T分期(OR=2.326,95%CI:1.758~3.078,P=0.000)及切除淋巴结数≥12枚(OR=2.998,95%CI:2.142~4.195,P=0.000)是淋巴结转移的独立危险因素。
贲门癌淋巴结转移率较高。转移主要发生在贲门周围、胃小弯、胃左动脉及胰后。肿瘤浸润深度及淋巴结清扫数是淋巴结转移的独立危险因素。